Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: Single-center experience

CardioVascular and Interventional Radiology

Volumn 34, Issue 3, 2011, Pages 557-565

  Seki, Akihiko ^a   Hori, Shinich ^a   Kobayashi, Kazuya ^a   Narumiya, Seizi ^a  

^a GateTower Institute for Image Guided Therapy   (Japan)

Author keywords

Drug eluting microspheres; HepaSpheres; Hepatic artery damage; Hepatocellular carcinoma; TACE

Indexed keywords

ANTIEMETIC AGENT; EPIRUBICIN; GELATIN SPONGE; MICROSPHERE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; SUPERABSORBENT POLYMER MICROSPHERE; UNCLASSIFIED DRUG;

ABDOMINAL DISEASE; ABDOMINAL PAIN; ABDOMINAL WALL REDNESS; ADULT; AGED; ANEMIA; ARTERY INJURY; ARTICLE; BILOMA; BLOOD TOXICITY; BLOOD TRANSFUSION; CHEMOEMBOLIZATION; CHOLECYSTITIS; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG SAFETY; FEMALE; FEVER; HEPATIC ARTERY; HUMAN; IATROGENIC DISEASE; JAPAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SHOULDER PAIN; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EPIRUBICIN; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; POLYMERS; TREATMENT OUTCOME;

EID: 79959602694     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9975-y     Document Type: Article

References (34)

1. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576 (Pubitemid 46890874)
2. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430 (Pubitemid 32844200)
3. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524 (Pubitemid 34183954)
4. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442 (Pubitemid 36152543)
5. Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization verses systemic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734-1739 (Pubitemid 34607087)
6. Brown DB, Cardella JF, Sacks D et al (2009) Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 20(Suppl 7):S219-S226
7. Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 31:756-761
8. Cammà C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47-54 (Pubitemid 34680374)
9. Chang JM, Tzeng WS, Pan HB et al (1994) Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study. Cancer 74:2449-2453
10. Kawai S, Okamura J, Ogawa M et al (1992) Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma: a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. Cancer Chemother Pharmacol 31(Suppl):S1-S6
11. Maeda N, Osuga K, Mikami K et al (2008) Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 26:206-212 (Pubitemid 351754724)
12. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474-481 (Pubitemid 46201723)
13. Malagari K, Chatzimichael K, Alexopoulou E et al (2008) Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc Interv Radiol 31:269-280
14. Grosso M, Vignali C, Quaretti P et al (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicenter study. Cardiovasc Intervent Radiol 31:1141-1149
15. Poon RT, Tso WK, Pang RW et al (2007) A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5:1100-1108
16. Kettenbach J, Stadler A, Katzler IV et al (2008) Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol 31:468-476
17. Hong K, Khwaja A, Liapi E et al (2006) New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2563-2567
18. Lewis AL, Gonzalez MV, Leppard SW et al (2007) Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci Mater Med 18:1691-1699 (Pubitemid 47224923)
19. Lammer J, Malagari K, Vogl T et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41-52
20. Reyes DK, Vossen JA, Kamel IR et al (2009) Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the United States. Cancer J 15:526-532
21. Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 31:1108-1116
22. Lacouture ME, Maitland ML, Segaert S et al (2010) A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 18:509-522
23. Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335-342 (Pubitemid 44341453)
24. Brown KT, Nevins AB, Getrajdman GI et al (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822-828 (Pubitemid 28427845)
25. Chan AO, Yuen MF, Hui CK et al (2002) A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 94:1747-1752 (Pubitemid 34241113)
26. Shim JH, Park JW, Choi JI et al (2009) Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma? J Vasc Interv Radiol 20:209-216
27. Kim JH, Chung JW, Han JK et al (1995) Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. J Vasc Interv Radiol 6:71-74
28. Park SI, Lee DY, Won JY, Lee JT (2003) Extrahepatic collateral supply of hepatocellular carcinoma by the intercostal arteries. J Vasc Interv Radiol 14:461-468 (Pubitemid 36423167)
29. Won JY, Lee DY, Lee JT et al (2003) Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma. Cardiovasc Intervent Radiol 26:136-140 (Pubitemid 36919553)
30. Miyayama S, Yamashiro M, Okuda M et al (2010) The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization. Cardiovasc Intervent Radiol 33:513-522
31. Miyayama S, Yamashiro M, Okuda M et al (2010) Hepatocellular carcinoma supplied by the right lumbar artery. Cardiovasc Intervent Radiol 33:53-60
32. Geschwind JF, Ramsey DE, Choti MA et al (2003) Chemoembolization of hepatocellular carcinoma: results of a meta-analysis. Am J Clin Oncol 26:344-349 (Pubitemid 36962074)
33. Ikeda M, Okada S, Yamamoto S et al (2002) Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Jpn J Clin Oncol 32:455-460 (Pubitemid 43102766)
34. Lladó L, Virgili J, Figueras J et al (2000) A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 88:50-57 (Pubitemid 30027678)